Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns

Date:




The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

ANIMALS AS LEADERS Announces European Festival & Club Dates

Animals As Leaders are heading back to Europe this...

The World’s Energy Safety Net Is Buckling

The Iran war has hit every node in the...

2026 NFL free agency class rankings: Most improved rosters

Ben SolakMar 25, 2026, 06:35 AM ETCloseBen Solak joined...

Stocks rally, oil prices fall after U.S. sends Iran a peace plan

U.S. stocks rose Wednesday and global oil prices fell...